Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life. (2025). Research, Society and Development, 14(5), e4914548812. https://doi.org/10.33448/rsd-v14i5.48812